West Pharmaceutical Services Inc.

WST ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008
Operating Activities
Net Income $72.6M $86.0M
Depreciation & Amortization $68.1M
Depreciation $63.9M $56.1M
Amortization $3.8M
Stock-Based Compensation $7.5M $6.4M
Net Cash from Operating Activities $137.7M $135.0M
Investing Activities
Capital Expenditures $104.9M $138.6M
Business Acquisitions $16.9M $0
Net Cash from Investing Activities $-121.9M $-119.7M
Financing Activities
Dividends Paid $20.1M $18.6M
Stock Repurchases $1.3M $5.2M
Net Cash from Financing Activities $-22.6M $-29.4M
Net Change in Cash $-4.1M $-21.2M
Free Cash Flow $32.8M $-3.6M
← Newer Page 3 of 3 Older →